Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.

Nault JC, Couchy G, Balabaud C, Morcrette G, Caruso S, Blanc JF, Bacq Y, Calderaro J, Paradis V, Ramos J, Scoazec JY, Gnemmi V, Sturm N, Guettier C, Fabre M, Savier E, Chiche L, Labrune P, Selves J, Wendum D, Pilati C, Laurent A, De Muret A, Le Bail B, Rebouissou S, Imbeaud S; GENTHEP Investigators, Bioulac-Sage P, Letouzé E, Zucman-Rossi J.

Gastroenterology. 2017 Mar;152(4):880-894.e6. doi: 10.1053/j.gastro.2016.11.042. Epub 2016 Dec 7.

2.

Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.

Calderaro J, Labrune P, Morcrette G, Rebouissou S, Franco D, Prévot S, Quaglia A, Bedossa P, Libbrecht L, Terracciano L, Smit GP, Bioulac-Sage P, Zucman-Rossi J.

J Hepatol. 2013 Feb;58(2):350-7. doi: 10.1016/j.jhep.2012.09.030. Epub 2012 Oct 6.

PMID:
23046672
3.

Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis.

Calderaro J, Nault JC, Balabaud C, Couchy G, Saint-Paul MC, Azoulay D, Mehdaoui D, Luciani A, Zafrani ES, Bioulac-Sage P, Zucman-Rossi J.

Mod Pathol. 2016 Jan;29(1):43-50. doi: 10.1038/modpathol.2015.119. Epub 2015 Oct 30.

4.

GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.

Nault JC, Fabre M, Couchy G, Pilati C, Jeannot E, Tran Van Nhieu J, Saint-Paul MC, De Muret A, Redon MJ, Buffet C, Salenave S, Balabaud C, Prevot S, Labrune P, Bioulac-Sage P, Scoazec JY, Chanson P, Zucman-Rossi J.

J Hepatol. 2012 Jan;56(1):184-91. doi: 10.1016/j.jhep.2011.07.018. Epub 2011 Aug 9.

PMID:
21835143
5.

Molecular classification of hepatocellular adenoma in clinical practice.

Nault JC, Paradis V, Cherqui D, Vilgrain V, Zucman-Rossi J.

J Hepatol. 2017 Nov;67(5):1074-1083. doi: 10.1016/j.jhep.2017.07.009. Epub 2017 Jul 19. Review.

PMID:
28733222
6.

Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.

Pilati C, Letouzé E, Nault JC, Imbeaud S, Boulai A, Calderaro J, Poussin K, Franconi A, Couchy G, Morcrette G, Mallet M, Taouji S, Balabaud C, Terris B, Canal F, Paradis V, Scoazec JY, de Muret A, Guettier C, Bioulac-Sage P, Chevet E, Calvo F, Zucman-Rossi J.

Cancer Cell. 2014 Apr 14;25(4):428-41. doi: 10.1016/j.ccr.2014.03.005.

7.

Hepatocellular Adenomas: Morphology and Genomics.

Bioulac-Sage P, Sempoux C, Balabaud C.

Gastroenterol Clin North Am. 2017 Jun;46(2):253-272. doi: 10.1016/j.gtc.2017.01.003. Review.

PMID:
28506364
8.

Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.

Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, Leteurtre E, Paradis V, Michalak S, Wendum D, Chiche L, Fabre M, Mellottee L, Laurent C, Partensky C, Castaing D, Zafrani ES, Laurent-Puig P, Balabaud C, Bioulac-Sage P.

Hepatology. 2006 Mar;43(3):515-24.

PMID:
16496320
9.

Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.

Margolskee E, Bao F, de Gonzalez AK, Moreira RK, Lagana S, Sireci AN, Sepulveda AR, Remotti H, Lefkowitch JH, Salomao M.

Diagn Pathol. 2016 Mar 9;11:27. doi: 10.1186/s13000-016-0475-5.

10.

Subtype classification of hepatocellular adenoma.

Bioulac-Sage P, Balabaud C, Zucman-Rossi J.

Dig Surg. 2010;27(1):39-45. doi: 10.1159/000268406. Epub 2010 Apr 1.

11.

Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas.

Nault JC, Couchy G, Caruso S, Meunier L, Caruana L, Letouzé E, Rebouissou S, Paradis V, Calderaro J, Zucman-Rossi J.

Hepatology. 2018 Sep;68(3):964-976. doi: 10.1002/hep.29884. Epub 2018 Jun 6.

PMID:
29572896
12.

Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression.

Rebouissou S, Franconi A, Calderaro J, Letouzé E, Imbeaud S, Pilati C, Nault JC, Couchy G, Laurent A, Balabaud C, Bioulac-Sage P, Zucman-Rossi J.

Hepatology. 2016 Dec;64(6):2047-2061. doi: 10.1002/hep.28638. Epub 2016 Jun 11.

PMID:
27177928
13.

Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.

Shafizadeh N, Genrich G, Ferrell L, Kakar S.

Hum Pathol. 2014 May;45(5):976-83. doi: 10.1016/j.humpath.2013.12.011. Epub 2014 Jan 8.

PMID:
24746201
14.

Hepatocellular adenoma management: call for shared guidelines and multidisciplinary approach.

Blanc JF, Frulio N, Chiche L, Sempoux C, Annet L, Hubert C, Gouw AS, de Jong KP, Bioulac-Sage P, Balabaud C.

Clin Res Hepatol Gastroenterol. 2015 Apr;39(2):180-7. doi: 10.1016/j.clinre.2014.10.003. Epub 2014 Nov 26.

PMID:
25434466
15.

Distinct Involvement of the Sonic Hedgehog Signaling Pathway in Gastric Adenocarcinoma of Fundic Gland Type and Conventional Gastric Adenocarcinoma.

Tajima Y, Murakami T, Saito T, Hiromoto T, Akazawa Y, Sasahara N, Mitomi H, Yao T, Watanabe S.

Digestion. 2017;96(2):81-91. doi: 10.1159/000478999. Epub 2017 Jul 22.

PMID:
28738329
16.

Molecular classification of hepatocellular adenomas.

Nault JC, Zucman Rossi J.

Int J Hepatol. 2013;2013:315947. doi: 10.1155/2013/315947. Epub 2013 Jan 15.

17.

Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.

Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, Laurent C, Blanc JF, Cubel G, Trillaud H, Zucman-Rossi J, Balabaud C, Saric J.

Hepatology. 2009 Aug;50(2):481-9. doi: 10.1002/hep.22995.

PMID:
19585623
18.

Retrospective study of hepatocellular adenomas based on the phenotypic classification system: A report from China.

Pan J, Chen L, Fan J, Zhou J, Qin L, Tan Y, Ji Y, Huang X.

Histol Histopathol. 2014 Feb;29(2):243-9. doi: 10.14670/HH-29.243. Epub 2013 Aug 13.

PMID:
23939475
19.

[Gp130-activating mutations in inflammatory liver adenomas].

Zucman-Rossi J, Amessou M, Bioulac-Sage P, Rebouissou S.

Med Sci (Paris). 2008 Dec;24(12):1113-4. doi: 10.1051/medsci/200824121113. French. No abstract available.

20.

Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.

Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, Rullier A, Cubel G, Couchy G, Imbeaud S, Balabaud C, Zucman-Rossi J.

Hepatology. 2007 Sep;46(3):740-8.

PMID:
17663417

Supplemental Content

Support Center